Lucy I. Crouch

Lucy I. Crouch

Auto-generated profile, based on publicly available information

Lucy I. Crouch

Department of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
JBJustina Briliūtė
Justina Briliūtė
PUPaulina A. Urbanowicz
Paulina A. Urbanowicz
ALAna S Luis
Ana S Luis
ABArnaud Baslé
Arnaud Baslé
NPNeil Paterson
Neil Paterson
LCLucy I. Crouch
Lucy I. Crouch

11 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
LCLucy I. Crouch
Lucy I. Crouch
MLMarcelo V. Liberato
Marcelo V. Liberato
PUPaulina A. Urbanowicz
Paulina A. Urbanowicz
ABArnaud Baslé
Arnaud Baslé
CLChristopher A. Lamb
Christopher A. Lamb
DBDavid N. Bolam
David N. Bolam
The thick mucus layer of the gut provides a barrier to infiltration of the underlying epithelia by both the normal microbiota and enteric pathogens. Some members of the microbiota utilise mucin glycoproteins as a nutrient source, but a detailed understanding of the mechanisms used to breakdown these complex macromolecules is lacking. Here we describe the discovery and characterisation of endo-acting enzymes from prominent mucin-degrading bacteria that target the polyLacNAc structures within oligosaccharide side chains of both animal and human mucins. These O-glycanases are part of the large and diverse glycoside hydrolase 16 (GH16) family and are often lipoproteins, indicating that they are surface located and thus likely involved in the initial step in mucin breakdown. These data provide a significant advance in our knowledge of the mechanism of mucin breakdown by the normal microbiota. Furthermore, we also demonstrate the potential use of these enzymes as tools to explore changes in O-glycan structure in a number of intestinal disease states.

31 January 2025 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
CBCassie R. Bakshani
Cassie R. Bakshani
TOTaiwo O. Ojuri
Taiwo O. Ojuri
BPBo Pilgaard
Bo Pilgaard
JHJesper Holck
Jesper Holck
RMRoss McInnes
Ross McInnes
LCLucy I. Crouch
Lucy I. Crouch
Akkermansia muciniphila is a human microbial symbiont residing in the mucosal layer of the large intestine. Its main carbon source is the highly heterogeneous mucin glycoprotein, and it uses an array of carbohydrate-active enzymes and sulfatases to access this complex energy source. Here we describe the biochemical characterization of 54 glycoside hydrolases, 11 sulfatases and 1 polysaccharide lyase from A. muciniphila to provide a holistic understanding of their carbohydrate-degrading activities. This was achieved using a variety of liquid chromatography techniques, mass spectrometry, enzyme kinetics and thin-layer chromatography. These results are supported with A. muciniphila growth and whole-cell assays. We find that these enzymes can act synergistically to degrade the O-glycans on the mucin polypeptide to completion, down to the core N-acetylgalactosaime. In addition, these enzymes can break down human breast milk oligosaccharide, ganglioside and globoside glycan structures, showing their capacity to target a variety of host glycans. These data provide a resource to understand the full degradative capability of the gut microbiome member A. muciniphila.

19 September 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LCLucy I. Crouch
Lucy I. Crouch
PUPaulina A. Urbanowicz
Paulina A. Urbanowicz
ABArnaud Baslé
Arnaud Baslé
ZCZhipeng Cai
Zhipeng Cai
LLLi Liu
Li Liu
DBDavid N. Bolam
David N. Bolam
The major nutrients available to the human colonic microbiota are complex glycans derived from the diet. To degrade this highly variable mix of sugar structures, gut microbes have acquired a huge array of different carbohydrate-active enzymes (CAZymes), predominantly glycoside hydrolases, many of which have specificities that can be exploited for a range of different applications. Plant N -glycans are prevalent on proteins produced by plants and thus components of the diet, but the breakdown of these complex molecules by the gut microbiota has not been explored. Plant N -glycans are also well characterized allergens in pollen and some plant-based foods, and when plants are used in heterologous protein production for medical applications, the N -glycans present can pose a risk to therapeutic function and stability. Here we use a novel genome association approach for enzyme discovery to identify a breakdown pathway for plant complex N -glycans encoded by a gut Bacteroides species and biochemically characterize five CAZymes involved, including structures of the PNGase and GH92 α-mannosidase. These enzymes provide a toolbox for the modification of plant N -glycans for a range of potential applications. Furthermore, the keystone PNGase also has activity against insect-type N -glycans, which we discuss from the perspective of insects as a nutrient source.

11 December 2023 in Trends in Microbiology
Verified
Journal Article
Open access
CBCassie R. Bakshani
Cassie R. Bakshani
LCLucy I. Crouch
Lucy I. Crouch
Several bacterial species initially colonise the infant gut, but are outcompeted. Human milk oligosaccharides (HMOs) in breast milk create an environment for Bifidobacterium to flourish. Laursen and Roager recently showed a clear link between breast milk and the dominance of Bifidobacterium longum subsp. infantis in the infant gut.

10 October 2024 in Seminars in Immunology
Verified
Journal Article
Open access
LCLucy I. Crouch
Lucy I. Crouch
CRCláudia S. Rodrigues
Cláudia S. Rodrigues
CBCassie R. Bakshani
Cassie R. Bakshani
LTLeticia Tavares-Gomes
Leticia Tavares-Gomes
JGJoana Gaifem
Joana Gaifem
SPSalomé Pinho
Salomé Pinho
The human gut microbiota is home to a diverse collection of microorganisms that has co-evolved with the host immune system in which host-microbiota interactions are essential to preserve health and homeostasis. Evidence suggests that the perturbation of this symbiotic host-microbiome relationship contributes to the onset of major diseases such as chronic inflammatory diseases including Inflammatory Bowel Disease. The host glycocalyx (repertoire of glycans/sugar-chains at the surface of gut mucosa) constitutes a major biological and physical interface between the intestinal mucosa and microorganisms, as well as with the host immune system. Glycans are an essential niche for microbiota colonization and thus an important modulator of host-microorganism interactions both in homeostasis and in disease. In this review, we discuss the role of gut mucosa glycome as an instrumental pathway that regulates host-microbiome interactions in homeostasis but also in health to inflammation transition. We also discuss the power of mucosa glycosylation remodelling as an attractive preventive and therapeutic strategy to preserve gut homeostasis.